We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open503
High511.75
Low501.45
Prev. Close499.7
Avg. Traded Price507.12
Volume12,62,965

MARKET DEPTH

info2
Total bid1,99,709.00
Total ask3,21,572.00
OrdersQtyBid
130507.85
116507.65
362507.6
459507.55
5145507.5
AskQtyOrders
507.97231
507.95142728
508333912
508.0571323
508.110377

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

501.45an hour ago
511.753 hours ago
arrow

LOWER/UPPER CIRCUITS

449.75
549.65
arrow
Granules India Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Net Profit,rose 23.74% in the last year to ₹501.52 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 24.18, lower than its sector PE ratio of 43.7.
noteQuarterly Revenue,rose 1.84% YoY to ₹1,199.35 Cr. Its sector's average revenue growth YoY for the quarter was 11.42%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 30.32%
Net profit growth 5Y CAGR : 16.65%
Granules India Ltd Top mutual funds holding
arrow
Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.
personal

Grow your wealth with more research recommendations

+91